Advertisement

FDA Delays Decision on Moderna RSV Shot by 3 Weeks

FDA Delays Decision on Moderna RSV Shot by 3 Weeks

The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.